Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Fuji
Medtronic
US Department of Justice
Cerilliant
Merck
Express Scripts
McKesson

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Obatoclax

« Back to Dashboard

US Patents for Obatoclax

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Obatoclax ➤ Sign Up Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases Gemin X Pharmaceuticals Canada inc. (Montreal, CA) ➤ Sign Up
Obatoclax ➤ Sign Up Methods for treating cancer Gemin X Pharmaceuticals Canada Inc. (Montreal, CA) ➤ Sign Up
Obatoclax ➤ Sign Up Triheterocyclic compounds and compositions thereof Gemin X Pharmaceuticals Canada Inc. (Montreal, Quebec, CA) ➤ Sign Up
Obatoclax ➤ Sign Up Combination therapy for MDS Children's Hospital Medical Center (Cincinnati, OH) ➤ Sign Up
Obatoclax ➤ Sign Up Methods for treatment of lymphomas with mutations in cell cycle genes MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Obatoclax

Drugname Country Document Number Estimated Expiration Related US Patent
Obatoclax Austria 546456 2023-05-30 ➤ Sign Up
Obatoclax Australia 2004242928 2023-05-30 ➤ Sign Up
Obatoclax Brazil PI0410870 2023-05-30 ➤ Sign Up
Obatoclax Canada 2527583 2023-05-30 ➤ Sign Up
Obatoclax China 1832939 2023-05-30 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Accenture
AstraZeneca
Fish and Richardson
Mallinckrodt
Federal Trade Commission
Julphar
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.